HC Wainwright assumed coverage on shares of Nkarta (NASDAQ:NKTX – Free Report) in a report issued on Monday, MarketBeat.com reports. The brokerage issued a buy rating on the stock. HC Wainwright also issued estimates for Nkarta’s Q3 2026 earnings at ($0.46) EPS, Q4 2026 earnings at ($0.48) EPS, FY2026 earnings at ($1.86) EPS, FY2027 earnings at ($2.26) EPS, FY2028 earnings at ($1.76) EPS, FY2029 earnings at ($1.57) EPS and FY2030 earnings at ($1.36) EPS.
Several other equities research analysts also recently commented on NKTX. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Nkarta in a research note on Monday, September 21st. Wall Street Zen lowered shares of Nkarta from a “sell” rating to a “strong sell” rating in a report on Saturday, August 15th. Finally, Stifel Nicolaus dropped their price objective on shares of Nkarta from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $11.20.
Nkarta Trading Up 13.1%
Shares of NASDAQ:NKTX opened at $1.73 on Monday. Nkarta has a 1-year low of $1.48 and a 1-year high of $3.72. The stock has a market capitalization of $123.90 million, a P/E ratio of -1.10 and a beta of 1.24. The business has a 50-day moving average price of $2.38 and a two-hundred day moving average price of $2.52.
Nkarta (NASDAQ:NKTX – Get Free Report) last issued its earnings results on Monday, August 10th. The company reported ($0.54) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.36) by ($0.18). As a group, equities analysts predict that Nkarta will post -1.60 EPS for the current year.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of NKTX. BlackRock Inc. acquired a new position in Nkarta during the 2nd quarter worth approximately $17,830,000. Monaco Asset Management SAM bought a new position in shares of Nkarta during the 2nd quarter worth approximately $6,717,000. AWM Investment Company Inc. bought a new position in shares of Nkarta during the 2nd quarter worth approximately $2,564,000. Forefront Analytics LLC acquired a new stake in shares of Nkarta in the second quarter valued at approximately $82,000. Finally, Ieq Capital LLC acquired a new stake in shares of Nkarta in the second quarter valued at approximately $501,000. 80.54% of the stock is currently owned by institutional investors.
Nkarta News Roundup
Here are the key news stories impacting Nkarta this week:
- Positive Sentiment: HC Wainwright assigned Nkarta a Buy rating, a favorable analyst view that may bolster investor confidence. HC Wainwright Begins Coverage on Nkarta
- Negative Sentiment: The firm forecasts losses of $1.86 per share for FY2026 and $2.26 for FY2027, with additional losses projected through FY2030. Its FY2026 estimate is more pessimistic than the cited consensus of a $1.52-per-share loss, which could weigh on sentiment. HC Wainwright Begins Coverage on Nkarta
About Nkarta
Nkarta, Inc is a clinical-stage biotechnology company focused on developing engineered natural killer (NK) cell therapies for cancer and autoimmune diseases. The company’s platform is designed to produce allogeneic, or donor-derived, NK cells that can be engineered with chimeric antigen receptors (CARs) to recognize and attack targeted cells.
Nkarta’s research and development programs have included NKX019, a CD19-targeted CAR NK-cell therapy investigated for B-cell malignancies and autoimmune disorders, and NKX101, an NKG2D-targeted CAR NK-cell therapy developed for certain solid tumors.
Further Reading
- Five stocks we like better than Nkarta
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Nkarta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nkarta and related companies with MarketBeat.com's FREE daily email newsletter.
